ANAPTYSBIO (ANABV) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 2 7 sessions, April 6, 2026 to April 17, 2026
- Largest daily move
- -5.5% close of April 16, 2026
Company Description
ANABV has declined 6.6% over the past week. The last closing price was $43.80.
For FY2025, ANAPTYSBIO reported revenue of $234.6M with net income of -$13.2M and diluted earnings per share of -$0.46. The company operates at a net profit margin of -5.6%.
This page collects what Stock Titan holds for ANABV, including price data, SEC filings, and financial highlights.
Stock Performance
ANAPTYSBIO (ANABV) closed at $43.80 on April 17, 2026. Over the past week, the price has lost 6.6%.
ANABV Metrics & Rankings
Price returns through April 17, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
ANAPTYSBIO has filed 10 recent SEC filings, including 9 Form 144, 1 Form 8-K. The most recent filing was submitted on June 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ANABV SEC filings →
Financial Highlights
ANAPTYSBIO generated $234.6M in revenue in FY2025, operating income reached $47.9M (20.4% operating margin), and net income was -$13.2M, reflecting a -5.6% net profit margin. Diluted earnings per share stood at -$0.46. The company generated $19.7M in operating cash flow. The current ratio was 9.07, measuring current assets divided by current liabilities.